Announcements Trials

Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 54 Neoplasms 38 Lung Neoplasms 24 Colorectal Neoplasms 24 Prostatic Neoplasms 17 Uterine Cervical Neoplasms 14 Motor Activity 13 Colonic Neoplasms 11 Carcinoma, Non-Small-Cell Lung 10 Rectal Neoplasms 9 Pancreatic Neoplasms 9 Hematologic Neoplasms 9 Anxiety Disorders 9 Urinary Bladder Neoplasms 8 Obesity 8 Melanoma 8 Lymphoma 8 Depression 8 Ovarian Neoplasms 7 Endometrial Neoplasms 7 Vulvar Neoplasms 6 Neoplasm Metastasis 6 Head and Neck Neoplasms 6 Breast Carcinoma In Situ 6 Sarcoma 5 Papillomavirus Infections 5 Pain 5 Leukemia, Myeloid, Acute 5 Hematopoietic and Lymphatic System Neoplasm 5 Triple Negative Breast Neoplasms 4

Interventions

Tenofovir 5 entecavir 3 peginterferon alfa-2b 2 peginterferon alfa-2a 1 ibrutinib 1 durvalumab 1 babao dan 1 Radiofrequency Ablation 1 Observation 1 Nucleosides 1 Methods 1 Interferons 1 Cholecalciferol 1 Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hepatitis B, Chronic × Methods × Clear all

NCT07120750 2025-08-13

PRTRAS 001

Shenzhen Third People's Hospital

Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis B, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡